Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Transdifferentiation—Alive Again?
May 1 2004. Just when many stem cell researchers had given up the ghost on the potential for adult stem cells to transdifferentiate into cells of other lineages, along comes new data to rekindle the debate. Reporting in tomorrow’s Lancet, Edward Scott and colleagues of the Program in Stem Cell Biology and Regenerative Medicine, University of Florida, Gainesville, have taken a retrospective, postmortem look at three women who had received hematopoietic transplants from male donors. Their findings, that male neural cells are present in the hippocampus of all three women, up to six years after transplantation, suggest that cells of the blood lineage can indeed give rise to cells of other lineages.

Hope that transdifferentiation would allow scientists to generate different tissue types from adult stem cells—and thus solve technical problems of tissue compatibility and ethical concerns about using embryonic stem cells—peaked a few years ago (e.g. see Mezey et al 2000). These hopes were then dashed when researchers reported that supposed transdifferentiated cells were actually chimeras that resulted from fusion of host and donor cells (see related news item ). In today’s Lancet paper however, first author Christopher Cogle and colleagues seem to rule out fusion as an explanation for male neurons in female brains. Using fluorescence in situ hybridization, Cogle tested brain samples from the three women for cells harboring X or Y chromosomes. This karyotyping showed that XY microglia were present in all samples. Though the authors failed to detect XY neurons or astrocytes in two of the women, who had died shortly after receiving peripheral blood stem cell transplants, they did find these cells in samples taken from the third woman, who had lived for 6 years after a bone marrow transplant.

Significantly, the authors failed to detect any XXY or XXXY cells. In addition, none of the women had had a male child, thus ruling out the possibility that XY neural stem cells from a fetus had once made their way into the brain tissue of the mother, a phenomenon known as post-partum microchimerism. Importantly, in the patient that had received the bone marrow transplant about 1% of neurons and astrocytes were male, a considerable amount. The authors suggest that previous CNS damage, caused by radiation and high-dose chemotherapy, may have created fertile ground for a bone marrow cell to transdifferentiate. It is also significant that most of the XY neurons were found in the subgranular layer of the dentate gyrus, one of only two sites in mammalian brains where neurogenesis is known to take place in adults.

According to the authors, these results suggest “that a transplantable haemopoietic cell responds to instructive neurotrophic cues, crosses the blood-brain barrier, migrates into CNS parenchyma, and activates neural-specific genetic programming.” In other words, the authors say, bone marrow can make brain. However, more experiments may be needed to convince many stem cell researchers. "The data may indicate that cells capable of providing neural cell differentiation were present in the grafts, but do not directly demonstrate that those were the same cells that provided hematopoietic engraftment," said David Scadden director of the Center for Regenerative Medicine and Technology at Massachusetts General Hospital, and codirector of the recently announced Harvard Stem Cell Institute. It will be interesting to see where the stem cell transdifferentiation debate goes from here (see related live discussion).—Tom Fagan.

Reference:
Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, Scott EW. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet May 1 2004;363:1432-1437. Abstract

 
Comments on News and Primary Papers
  Comment by:  Mary Reid
Submitted 11 May 2004  |  Permalink Posted 14 May 2004

Would there be room for the suggestion that AML stem cells may also migrate to the brain to form astrocytes? It seems of interest that Baldus et al(1) find overexpression of APP, ETS2 and ERG genes in AML. Wolvetang and colleagues (2)show that ETS2 transactivates the beta-APP promoter. Amouyel et al (3) report the expression of ETS proto-oncogenes in astrocytes. Delabar et al (4) report the overexpression of ETS2 in AD. Interesting that HIV-1 infection induces expression of c-kit (5) and Ets-2 is suggested as playing a role in the expression of c-kit. (6) The study by Lu (7) that ETS2 transactivates the heparanase promoter and that Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro (8) is also of interest. Bitan et al (9) find that heparanase in human leukemias is restricted to acute myeloid leukemias. Finally, the fact that ETS-2 is able to bind to the LIF promoter to induce its transcription (10) and LIF is able to increase the activity of acetylcholinesterase (11) may be something to consider....  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad